The following pages link to (Q4642533):
Displaying 6 items.
- A phase I-II basket trial design to optimize dose-schedule regimes based on delayed outcomes (Q2057378) (← links)
- On optimal designs for clinical trials: an updated review (Q2301225) (← links)
- A Bayesian Phase I/II Trial Design for Immunotherapy (Q4559685) (← links)
- Application of gamma process to two-agent combinations with delayed toxicity (Q5083969) (← links)
- A Bayesian adaptive design for addressing correlated late-onset outcomes in phase I/II randomized trials of drug combinations in oncology (Q5866135) (← links)
- gBOIN‐ET: The generalized Bayesian optimal interval design for optimal dose‐finding accounting for ordinal graded efficacy and toxicity in early clinical trials (Q6068828) (← links)
